261 related articles for article (PubMed ID: 7520770)
1. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
2. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
3. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
Cairo MS; Plunkett JM; Mauss D; Van de ven C
Blood; 1990 Nov; 76(9):1788-94. PubMed ID: 1699622
[TBL] [Abstract][Full Text] [Related]
4. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.
Cairo MS; Plunkett JM; Nguyen A; van de Ven C
Blood; 1992 Jul; 80(1):96-101. PubMed ID: 1377057
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
7. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
8. [Assessing the efficacy of the recombinant human granulocyte colony-stimulating factor "rhG-CSF" in the treatment of early neonatal sepsis in premature neonates].
Miura E; Procianoy RS; Bittar C; Miura CS; Melo C; Miura MS
J Pediatr (Rio J); 2000; 76(3):193-9. PubMed ID: 14647669
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
12. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.
Ohsaka A; Kitagawa S; Sakamoto S; Miura Y; Takanashi N; Takaku F; Saito M
Blood; 1989 Dec; 74(8):2743-8. PubMed ID: 2479431
[TBL] [Abstract][Full Text] [Related]
13. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
[TBL] [Abstract][Full Text] [Related]
14. The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure.
Akizawa T; Shishido K; Koshikawa S
Artif Organs; 1995 Dec; 19(12):1251-7. PubMed ID: 8967884
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
17. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Andrews RG; Briddell RA; Knitter GH; Opie T; Bronsden M; Myerson D; Appelbaum FR; McNiece IK
Blood; 1994 Aug; 84(3):800-10. PubMed ID: 7519077
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between the half-life and bone marrow myeloid cell pool.
Watari K; Ozawa K; Takahashi S; Tojo A; Tani K; Kamachi S; Asano S
Int J Hematol; 1997 Jul; 66(1):57-67. PubMed ID: 9220661
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
